Best Medication for Infected Wounds
For infected wounds, empiric antibiotic selection should be amoxicillin-clavulanate 875/125 mg twice daily for mild-to-moderate infections, or vancomycin plus piperacillin-tazobactam for severe infections, with dose adjustments required for impaired renal function. 1, 2
Initial Assessment and Severity Classification
Before selecting antibiotics, assess infection severity by examining for:
- Systemic signs: Temperature >38.5°C, heart rate >110 beats/minute, or erythema extending >5 cm beyond wound margins 2
- Necrotizing features: Rapidly spreading erythema, crepitus, systemic toxicity, or gangrene requiring immediate surgical consultation 1
- Wound characteristics: Presence of purulent drainage, deep tissue involvement, or exposed bone 1
Empiric Antibiotic Selection by Severity
Mild-to-Moderate Infections
First-line therapy targeting aerobic gram-positive cocci is sufficient for patients without recent antibiotic exposure: 1
- Amoxicillin-clavulanate 875/125 mg twice daily orally - provides coverage against staphylococci, streptococci, and anaerobes 1
- Alternative for penicillin allergy: Doxycycline 100 mg twice daily (covers staphylococci and anaerobes, though some streptococci may be resistant) 1
- Alternative for β-lactam hypersensitivity: Moxifloxacin 400 mg daily (provides monotherapy with good anaerobic coverage) 1
Severe Infections
Broad-spectrum parenteral therapy is required initially: 2, 1
- Vancomycin 30 mg/kg/day in 2 divided doses IV PLUS piperacillin-tazobactam - covers MRSA, gram-negatives, and anaerobes 2, 1
- Alternative regimen: Vancomycin plus ceftriaxone 1 g every 12 hours IV and metronidazole 500 mg every 8 hours IV 1, 2
- For diabetic foot infections: Piperacillin-tazobactam or ertapenem as monotherapy options 2
Special Considerations for Allergies
Penicillin Allergy
- Non-immediate hypersensitivity: Cefuroxime 500 mg twice daily or cefazolin 1 g every 8 hours IV 1
- Immediate hypersensitivity reactions: Avoid all β-lactams; use fluoroquinolone (ciprofloxacin 500-750 mg twice daily or levofloxacin 750 mg daily) plus metronidazole 500 mg three times daily 1
- Severe infections with β-lactam allergy: Vancomycin plus ciprofloxacin 400 mg every 12 hours IV plus metronidazole 1
MRSA Coverage Indications
Add empiric MRSA coverage when: 1
- Prior history of MRSA infection
- High local MRSA prevalence
- Clinically severe infection
- Recent antibiotic exposure
Dose Adjustments for Impaired Renal Function
Vancomycin Dosing in Renal Impairment 3
Initial dose should be at least 15 mg/kg regardless of renal function, followed by:
| Creatinine Clearance (mL/min) | Vancomycin Dose (mg/24h) |
|---|---|
| 100 | 1,545 |
| 70 | 1,080 |
| 50 | 770 |
| 30 | 465 |
| 10 | 155 |
- Functionally anephric patients: 15 mg/kg initial dose, then 1.9 mg/kg/24h maintenance 3
- Anuria: 1,000 mg every 7-10 days 3
- Monitor serum concentrations closely in renal impairment 3
Fluoroquinolone Adjustments 4
- Ciprofloxacin: Reduce dose by 50% when creatinine clearance <30 mL/min 5, 4
- Levofloxacin: Adjust dosing interval based on creatinine clearance 4
- Moxifloxacin: No dose adjustment needed (hepatic elimination) 1
β-Lactam Adjustments 4
- Amoxicillin-clavulanate: Extend dosing interval to every 12-24 hours when creatinine clearance <30 mL/min 4
- Piperacillin-tazobactam: Reduce to 2.25 g every 6 hours when creatinine clearance <40 mL/min 4
Route and Duration of Therapy
Route Selection 1
- Parenteral therapy: Required for all severe and some moderate infections initially 1
- Switch to oral: When patient is systemically well and culture results available 1
- Oral therapy alone: Acceptable for most mild and many moderate infections using highly bioavailable agents 1
Treatment Duration 1, 2
- Mild infections: 1-2 weeks 1
- Moderate-to-severe infections: 2-3 weeks 1
- Continue until resolution of infection signs, not complete wound healing 1
- Reassess at 48-72 hours and narrow therapy based on culture results 2
Critical Caveats
Culture Acquisition 1
- Obtain cultures before antibiotics by tissue sampling from debrided wound base, not swabs 1
- Cleanse and debride wound before obtaining specimens 1
- Do not culture clinically uninfected wounds 1
Surgical Intervention Priority 1, 2
- Antibiotics are adjunctive therapy - adequate debridement and drainage are most important 1, 2
- Seek surgical consultation for deep abscess, extensive bone involvement, crepitus, or necrotizing infection 1
- Temporarily discontinue negative pressure wound therapy (VAC) during active infection until debridement and antibiotics initiated 2
Resistance Prevention 2
- Avoid prolonged courses - increases resistance risk without additional benefit 2
- If failing therapy: Discontinue all antibiotics for several days, then obtain optimal culture specimens 1
- Pseudomonas coverage: Usually unnecessary except for specific risk factors (prior infection, chronic wounds, recent broad-spectrum antibiotics) 1